NRAS and melanoma: Despite the fact that the BRAFV600 mutation was the single most prevalent mutation in our melanoma population (51% of the melanomas had a BRAFV600 mutation), 41% of the melanoma tumors contained a PI3K mutation including 10 samples that were wild-type for BRAFV600 and NRAS.